|
SNM (formerly the Society of Nuclear Medicine) conducted a survey of nuclear pharmacies and discovered that 60 percent of the facilities were impacted by a shortage of molybdenum-99 (Mo-99).
The American Association of Physicists in Medicine (AAPM) has offered to provide the public with additional background information to help avoid a misinterpretation of the findings contained in a report issued March 3 by the National Council on Radiation Protection and Measurements (NCRP). Additionally, the Society of Nuclear Medicine (SNM) has urged Americans to consider the benefits of medical imaging.
Eliminating the highly enriched uranium process (HEU)—the primary source of medical isotopes in the United States—would be technically and economically feasible, however, the conversion to an alternative source will be years away, is likely to be more costly than the report estimates, and will not alleviate the current ongoing shortages, according to a report released Jan. 14 by the National Academy of Sciences (NAS).
|
Although evidence-based medicine has been the focus of work by many healthcare researchers, molecular imaging and nuclear medicine has received scant attention in this arena. Clinical colleagues in fields such as cardiology and oncology are able to routinely participate in multinational trials of the latest interventional devices and pharmaceutical agents.
More than 150 physicians, imagers and pharmaceutical developers convened to examine the need for streamlined drug discovery through the integration of imaging biomarkers into multi-center clinical trials, during the SNM Molecular Imaging Summit, Feb. 8-9 in Clearwater, Fla.
The Society of Nuclear Medicine (SNM) has created the Molecular Imaging
Clinical Trials Network in response to the need for streamlined
processes for using imaging biomarkers in clinical research and
practice.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.